Lords Mark India has acquired 85 per cent holding in Bengaluru based Renalyx Health Systems. The holding will increase to 92 per cent by March 2026. Lords Mark India stated that the company will continue to operate as an independent business unit.
Renalyx Health Systems is the developer of Renalyx, described as the world’s first AI powered Made in India sustained low efficiency dialysis machine (SLED). The company stated that RxT 21 is an AI powered and IoT-enabled smart haemodialysis machine with remote monitoring capabilities, clinical connectivity, real-time data access, support for telenephrology platforms and patient safety features.
Lords Mark India stated that the ISO and CE certified machine includes integration with the DNP database for centre operations and cloud based patient EMR management, one touch operation for dialysis sessions, SLED mode for intensive care, personalised dialysis prescriptions, Kt/V monitoring for adequacy and clearance validation, single needle dialysis support, endotoxin removal filter, and advanced sodium and ultrafiltration profiling.
The dialysis machine will be manufactured in collaboration with Bharat Electronics. Lords Mark stated that it received its manufacturing licence in September 2025.
Speaking on the acquisition, Sachidanand Upadhyay, Managing Director and CEO of Lords Mark Industries said, “This acquisition reinforces our commitment to driving self-reliance and innovation in India’s Medtech and Diagnostic ecosystem. With Renalyx Health Systems, we’re not only making advanced dialysis more accessible but also putting India on the global MedTech manufacturing map. Our goal is to scale this innovation worldwide, while ensuring that every patient, regardless of geography, has access to safe, efficient and affordable care.”
He added, “In April 2025 we shipped our first medtech order of contactless remote patient monitoring and AI based early warning systems worth 1mn dollars to the US. This was more than just an export order for us. The Medtech division of the company today has innovative solutions like TuBerculoScope – an AI enabled Tuberculosis diagnostic device, Aluminium Visual Detection Kit, Extra Cellular Acidity Analyser, Smart E Clinics, Dozee – a contactless AI enabled ICU monitoring solution besides others.”